Clinical research: Cancer drug could treat Angelman syndrome
A cancer drug shows promise as a treatment for Angelman syndrome, according to a study published today in Nature.
By
Jessica Wright
21 December 2011 | 2 min read
This article is more than five years old.
Neuroscience—and science in general—is constantly evolving, so older articles may contain information or theories that have been reevaluated since their original publication date.
References:
- Huang H-S. et al. Nature Epub ahead of print (2011) Abstract
Explore more from The Transmitter
Cocaine, morphine commandeer neurons normally activated by food, water in mice
By
Lauren Schenkman
8 May 2024 | 5 min read
X chromosome inactivation; motor difficulties in 16p11.2 duplication and deletion; oligodendroglia
By
Jill Adams
7 May 2024 | 2 min read
Decoding flies’ motor control with acrobat-scientist Eugenia Chiappe
By
Elissa Welle
7 May 2024 | 6 min read
Cite this article: